Last reviewed · How we verify
Test Product HY07121 — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Test Product HY07121 (Test Product HY07121) — Sichuan Huiyu Pharmaceutical Co., Ltd.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Test Product HY07121 TARGET | Test Product HY07121 | Sichuan Huiyu Pharmaceutical Co., Ltd | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Test Product HY07121 CI watch — RSS
- Test Product HY07121 CI watch — Atom
- Test Product HY07121 CI watch — JSON
- Test Product HY07121 alone — RSS
Cite this brief
Drug Landscape (2026). Test Product HY07121 — Competitive Intelligence Brief. https://druglandscape.com/ci/test-product-hy07121. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing